Silence Therapeutics Plc American Depository Share

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Silence Therapeutics Plc American Depository Share
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
United Kingdom
Headquarters city
London
Headquarters country
United Kingdom
Ticker symbol
SLN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001479615

Board of directors

Follow this board

Chief executives

Craig A. Tooman · President and CEO
Since January 2025

Board connections

2 of this board's directors also sit on 4 other boards.

Network of Silence Therapeutics Plc American Depository Share's board connections BioAge Labs Inc. BioAge Labs Inc. NewAmsterdam Pharma Company N.V. NewAmsterdam Pharma Co... Scilex Holding Company Scilex Holding Company Tenax Therapeutics Inc. Tenax Therapeutics Inc... David Lemus David Lemus Michael H. Davidson Michael H. Davidson Silence Therapeutics Plc A...
Shared director Other board Same sector

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.